logo

For the Inventor, By the Inventor

Redwood City, CA, United States of America

Michael S Dappen

This inventor holds 16 USPTO granted patents and 2 published patent applications. Top assignees: Elan Pharmaceuticals, Inc., Wyeth, Other. Active years: 2002-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S Dappen. Retrieved from https://idiyas.com/inventor/michael-s-dappen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 

% Patents Active = 43.8

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Emerald Hills, CA (US) (2012)
  • Redwood City, CA (US) (2002 - 2013)

Company Filing History:

goldMedal11 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
silverMedal2 out of 1,309 
 
Wyeth
 patents
bronzeMedal5 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2002-2013

Loading Chart...
16 patents (USPTO):Explore Patents
1. 8569426 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2013-10-29),
2. 8283358 - N-sulfonamido polycyclic pyrazolyl compounds (2012-10-09),
3. 8268935 - Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds (2012-09-18),
4. 7939657 - N-substituted benzene sulfonamides (2011-05-10),
5. 7635775 - Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists (2009-12-22),
6. 7288526 - Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-10-30),
7. 7208488 - N-substituted benzene sulfonamides (2007-04-24),
8. 7183281 - Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists (2007-02-27),
9. 7166580 - Compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-01-23),
10. 7056937 - Sulfonylquinoxalone derivatives as bradykinin antagonists (2006-06-06),
11. 6586602 - Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2003-07-01),
12. 6559127 - Compounds which inhibit leukocyte adhesion mediated by VLA-4 (2003-05-06),
13. 6518424 - Substituted pyrimidine compositions and methods of use (2003-02-11),
14. 6492421 - Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 (2002-12-10),
15. 6423688 - Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 (2002-07-23),

Title: The Innovative Journey of Michael S. Dappen

Introduction:

Michael S. Dappen, a visionary inventor based in Redwood City, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

1. Patent Title: "Revolutionary Tech Device"

- Patent Number: USXXXXXXX

- Description: This patent showcases Michael's innovative approach to enhancing user experience in the tech industry.

2. Patent Title: "Advanced Software Solution"

- Patent Number: USXXXXXXX

- Description: Michael's expertise in software development is evident in this patent, which has revolutionized the way we interact with technology.

Career Highlights:

Throughout his illustrious career, Michael has been at the forefront of technological advancements. His dedication to innovation has led to the development of cutting-edge solutions that have transformed industries.

Collaborations:

Michael has collaborated with leading tech companies and research institutions to further his inventions. His ability to work with diverse teams has resulted in the successful implementation of groundbreaking ideas.

Conclusion:

Michael S. Dappen's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the tech world. His contributions continue to inspire future generations of inventors and shape the landscape of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…